Rapid Micro Biosystems Reports First Quarter 2023 Financial Results
05 mai 2023 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2023 total revenue of $5.0 million, representing growth of 21%, compared to first quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing
04 mai 2023 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023
13 avr. 2023 16h05 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
11 janv. 2023 09h00 HE
|
Rapid Micro Biosystems, Inc.
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 2022 with approximately $140 million in cash and investments providing runway at least into 2026 ...
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
10 nov. 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
12 sept. 2022 09h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
12 août 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management Adopts Limited Duration Stockholder Rights Plan LOWELL, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro...
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
12 août 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports second quarter 2022 commercial revenue of $3.9 million Lowers full year 2022 commercial revenue guidance to at least $17.0 million Implements organizational restructuring plan to right-size...
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
09 août 2022 08h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
04 mars 2022 06h00 HE
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million ...